SCHEMBL4240346

SCHEMBL4240346

Oc1cc(-c2ccccn2)nc(-c2ccccn2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 3/20 0.64
CCR5 P51681 3/20 0.64
CCR8 P51685 3/20 0.64
KDM4E B2RXH2 8/20 0.64
LMNA P02545 3/20 0.64
TP53 P04637 3/20 0.64
ALOX15 P16050 3/20 0.64
L3MBTL1 Q9Y468 3/20 0.64
HTT P42858 2/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
TDP1 Q9NUW8 2/20 0.64
ALPL P05186 1/20 0.64
HSP90AA1 P07900 1/20 0.64
ALPI P09923 1/20 0.64
ALPG P10696 1/20 0.64
MAPK1 P28482 1/20 0.64
METAP1 P53582 2/20 0.61
CYP1A2 P05177 1/20 0.61
POLB P06746 1/20 0.61
BLM P54132 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2535113 0.98 CCR1 (0.62) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL14801936 0.91 CCR1 (0.55) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL6130692 0.88 CCR1 (0.56) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL11016110 0.87 KDM4E (0.50) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL1989717 0.84 KDM4E (0.67) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL4300914 0.84 CCR1 (0.47) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL3601601 0.83 NPC1 (0.63) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL1645534 0.83 KDM4E (0.61) CCR1CCR5CCR8KDM4ELMNA
Dipyridyl SCHEMBL9014332 0.83 KDM4E (0.61) CCR1CCR5CCR8KDM4ELMNA
Dipyridyl SCHEMBL9014126 0.83 KDM4E (0.61) CCR1CCR5CCR8KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082984-A1 BICHROMOPHORIC COMPOUNDS AND THEIR USES, NOTABLY IN THE STUDY OF METALLO-BIOMEDICAL AGENTS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-04-24 WO disclosed
EP-4541862-A1 BICHROMOPHORIC COMPOUNDS AND THEIR USES, NOTABLY IN THE STUDY OF METALLO-BIOMEDICAL AGENTS Centre National de la Recherche Scientifique (FR) 2025-04-23 EP disclosed
US-20230337670-A1 PHOTO-POLYMERIZABLE, UNIVERSAL ANTIMICROBIAL COATING TO PRODUCE HIGH-PERFORMING, MULTI-FUNCTIONAL FACE MASKS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2023-10-26 US disclosed
US-20230337670-A1 PHOTO-POLYMERIZABLE, UNIVERSAL ANTIMICROBIAL COATING TO PRODUCE HIGH-PERFORMING, MULTI-FUNCTIONAL FACE MASKS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2023-10-26 US disclosed
EP-3033409-B1 COMPOSITION CATEXEL TECH LIMITED (GB) 2021-09-22 EP disclosed
US-10724903-B2 Polymer encapsulated particles as surface enhanced Raman scattering probes NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2020-07-28 US disclosed
US-10370621-B2 Bleaching formulations comprising particles and transition metal ion-containing bleaching catalysts CHEMSENTI LIMITED (GB) 2019-08-06 US disclosed
EP-2970677-B1 SMALL SCALE MICROENCAPSULATED PIGMENTS AND USES THEREOF CHROMATIC TECH INC (US) 2018-11-21 EP disclosed
US-9695320-B2 Small scale microencapsulated pigments and uses thereof CHROMATIC TECHNOLOGIES, INC. (US) 2017-07-04 US disclosed
US-20160160160-A1 COMPOSITION CHEMSENTI LIMITED (GB) 2016-06-09 US disclosed
US-20070072787-A1 Stable particulate composition comprising bleach catalysts CIBA SPECIALTY CHEMICALS CORP. 2007-03-29 US disclosed
US-7161005-B2 Use of metal complex compounds as oxidation catalysts CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-01-09 US disclosed
US-7161005-B2 Use of metal complex compounds as oxidation catalysts CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-01-09 US disclosed
EP-0186869-B1 COLORLESS LIGAND-RELEASING MONOMERS AND POLYMERS AND THEIR USE TO PROVIDE DYES WITH METAL IONS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-03-14 EP disclosed
US-4680356-A Colorless ligand-releasing monomers and polymers and their use to provide dyes with metal ions EASTMAN KODAK COMPANY (US) 1987-07-14 US disclosed
EP-0186869-A2 Colorless ligand-releasing monomers and polymers and their use to provide dyes with metal ions EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-07-09 EP disclosed
EP-0186868-A2 Photographic element and process for providing metal complex color images EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-07-09 EP disclosed
US-4557998-A AVOIDS COUPLER SOLVENTS EASTMAN KODAK COMPANY (US) 1985-12-10 US disclosed
US-4555478-A Photographic element and process for providing metal complex color images EASTMAN KODAK COMPANY (US) 1985-11-26 US disclosed
US-4555477-A Photographic element and process utilizing metal complex color masking dyes EASTMAN KODAK COMPANY (US) 1985-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337670-A1 PHOTO-POLYMERIZABLE, UNIVERSAL ANTIMICROBIAL COATING TO PRODUCE HIGH-PERFORMING, MULTI-FUNCTIONAL FACE MASKS CUTA, PUF60, PARN CCR1 4675/4885CCR5 4554/4885CCR8 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.